Skip to main content

Pluri Inc.

PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001158780

No open-market purchases or sales by Pluri Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $55.3K in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Pluri Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of PLUR: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders3633−3
Shares919.8K695.8K−224.0K (−24.4%)
Value$732.6K$652.8K−$79.8K (−10.9%)

New holders (4)

Institutions that held Pluri Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to PLUR in Q4 2022
InstitutionSharesValue% of portfolio
Virtu Financial LLC16,740$16.0K0.00%
Citadel Advisors LLC15,323$14.4K0.00%
Two Sigma Securities, LLC14,243$13.4K0.00%
Altshuler Shaham Ltd4,000$3.76K0.00%

Sold out (7)

Institutions that held Pluri Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of PLUR in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Meitav Dash Investments Ltd167,593$131.0K
Millennium Management LLC20,412$16.0K
HighTower Advisors, LLC11,985$9.00K
JPMorgan Chase & Co1,565$1.00K
Baldwin Brothers Inc1,542$1.00K
TCI Wealth Advisors, Inc.99$0
BDO Wealth Advisors, LLC100$0